PHIL INTER PHARMA
LIVE

Serial Number

99571029

Owner

PHIL INTERNATIONAL CO., LTD.

Attorney

KWANG YUP CHAE

Filing Date

Dec 30, 2025

Add to watchlist:

No watchlists yet
View on USPTO

PHIL INTER PHARMA Trademark

Serial Number: 99571029

PHIL INTER PHARMA is a trademark filed by PHIL INTERNATIONAL CO., LTD. on December 30, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

PHIL INTERNATIONAL CO., LTD. (4 trademarks)

17 Nonhyeon-ro 99-gil, Gangnam-gu
Seoul 06126 , KR

Entity Type: 99

Trademark Details

Filing Date

December 30, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceuticals for the treatment of erectile dysfunction; Adrenal hormone preparations; Pharmaceutical preparations for urogenital organs; Vitamin preparations; Pharmaceutical products for the treatment of bone diseases; Crude drugs; Anti-inflammatory and antipyretic preparations; Pharmaceutical agents affecting digestive organs; Cardiovascular pharmaceutical preparations; Allergy medications; Chemico-pharmaceutical preparations; Pharmaceutical agents affecting sensory organs; Medicines for the treatment of gastrointestinal diseases; Nutraceutical preparations for therapeutic or medical purposes; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for use in dermatology; Antibiotic preparations; Pharmaceutical products for treating respiratory diseases and asthma

Testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; Drug discovery services; Pharmaceutical research and development; Analysis and evaluation of medical product development; Laboratory research services relating to pharmaceuticals; Clinical studies of medicines; Pharmaceutical product evaluation; Biotechnology research; Chemistry services; Chemical research and analysis; Scientific research in the field of biomedicine; Providing information relating to scientific research in the fields of biochemistry and biotechnology; Biochemistry research services; Scientific research in the field of pharmacy; Scientific research in the field of genetic engineering; Medicine research; Medical and pharmacological research services; Conducting clinical trials; Chemical engineering; Cosmetics development services

Wholesale store services for nutraceutical preparations mainly based on herbal extracts; Retail store services for nutraceutical preparations mainly based on herbal extracts; Import-export agency services; Wholesale store services for medical instruments; Retail store services for medical instruments; Wholesale store services for pharmaceuticals; Retail store services for pharmaceuticals; Wholesale store services for cosmetics; Retail store services for cosmetics; Wholesale store services for nutraceuticals for use as dietary supplements; Retail store services for veterinary preparations; Wholesale store services for medical apparatus and instruments; Advertising, marketing and publicity services; Promoting the goods and services of others by means of operating an on-line comprehensive shopping mall; Retail store services for nutraceutical preparations for therapeutic or medical purposes; Wholesale store services for medicines for human purposes; Retail store services for medicines for human purposes; Business intermediary services relating to mail order by telecommunications; Wholesale store services for industrial chemical machines for pharmaceutical processing; Retail store services for industrial chemical machines for pharmaceutical processing

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 7, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 7, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 7, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 29, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 19, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Dec 30, 2025 MAFR
NEW APPLICATION ENTERED
Dec 30, 2025 NWAP